Human gut bacteria as potent class I histone deacetylase inhibitors in vitro through production of butyric acid and valeric acid
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Human gut bacteria as potent class I histone deacetylase inhibitors in vitro through production of butyric acid and valeric acid
Authors
Keywords
Consortia, Gut bacteria, Butyric acids, Metabolites, Protein extraction, Bacteria, Epigenetics, Histones
Journal
PLoS One
Volume 13, Issue 7, Pages e0201073
Publisher
Public Library of Science (PLoS)
Online
2018-07-28
DOI
10.1371/journal.pone.0201073
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Microbiota derived short chain fatty acids promote histone crotonylation in the colon through histone deacetylases
- (2018) Rachel Fellows et al. Nature Communications
- Gas chromatography – mass spectrometry data processing made easy
- (2017) Lea G. Johnsen et al. JOURNAL OF CHROMATOGRAPHY A
- Progression of Parkinson's disease is associated with gut dysbiosis: Two-year follow-up study
- (2017) Tomomi Minato et al. PLoS One
- Can intestinal microbiota be associated with non-intestinal cancers?
- (2017) Camille Jacqueline et al. Scientific Reports
- Inhibiting Histone Deacetylase 2 (HDAC2) Promotes Functional Recovery From Stroke
- (2017) Ying Tang et al. Journal of the American Heart Association
- New evidences on the altered gut microbiota in autism spectrum disorders
- (2017) Francesco Strati et al. Microbiome
- Histone deacetylase 3 regulates the inflammatory gene expression programme of rheumatoid arthritis fibroblast-like synoviocytes
- (2016) Chiara Angiolilli et al. ANNALS OF THE RHEUMATIC DISEASES
- Formation of propionate and butyrate by the human colonic microbiota
- (2016) Petra Louis et al. ENVIRONMENTAL MICROBIOLOGY
- Interplay between diet, gut microbiota, epigenetic events, and colorectal cancer
- (2016) Scott J. Bultman MOLECULAR NUTRITION & FOOD RESEARCH
- Reduced diversity and altered composition of the gut microbiome in individuals with myalgic encephalomyelitis/chronic fatigue syndrome
- (2016) Ludovic Giloteaux et al. Microbiome
- The gut microbiota and Type 1 Diabetes
- (2015) Elke Gülden et al. CLINICAL IMMUNOLOGY
- Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota
- (2015) Kristoffer Forslund et al. NATURE
- Dysbiosis in the Gut Microbiota of Patients with Multiple Sclerosis, with a Striking Depletion of Species Belonging to Clostridia XIVa and IV Clusters
- (2015) Sachiko Miyake et al. PLoS One
- Review article: selective histone deacetylase isoforms as potential therapeutic targets in inflammatory bowel diseases
- (2014) C. Felice et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- New and emerging HDAC inhibitors for cancer treatment
- (2014) Alison C. West et al. JOURNAL OF CLINICAL INVESTIGATION
- The histone deacetylase Hdac1 regulates inflammatory signalling in intestinal epithelial cells
- (2014) Alexis Gonneaud et al. Journal of Inflammation-London
- Gut Microbes and the Brain: Paradigm Shift in Neuroscience
- (2014) E. A. Mayer et al. JOURNAL OF NEUROSCIENCE
- The gut microbiota influences blood-brain barrier permeability in mice
- (2014) V. Braniste et al. Science Translational Medicine
- Emerging roles of the microbiome in cancer
- (2013) S. J. Bultman CARCINOGENESIS
- Polyamines: Emerging players in bacteria–host interactions
- (2013) Maria Letizia Di Martino et al. INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY
- Histone deacetylase 3 coordinates commensal-bacteria-dependent intestinal homeostasis
- (2013) Theresa Alenghat et al. NATURE
- Profound impact of gut homeostasis on chemically-induced pro-tumorigenic inflammation and hepatocarcinogenesis in rats
- (2012) Hui-Lu Zhang et al. JOURNAL OF HEPATOLOGY
- Valproic acid mediates the synaptic excitatory/inhibitory balance through astrocytes — A preliminary study
- (2012) Chao-Chuan Wang et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Thailandepsins are new small molecule class I HDAC inhibitors with potent cytotoxic activity in ovarian cancer cells: a preclinical study of epigenetic ovarian cancer therapy
- (2012) Andrew J Wilson et al. Journal of Ovarian Research
- Phase 2 trial of romidepsin in patients with peripheral T-cell lymphoma
- (2011) R. L. Piekarz et al. BLOOD
- Exogenous Stimuli Maintain Intraepithelial Lymphocytes via Aryl Hydrocarbon Receptor Activation
- (2011) Ying Li et al. CELL
- Gut microbiota, probiotics, and vitamin D: Interrelated exposures influencing allergy, asthma, and obesity?
- (2011) Ngoc P. Ly et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Thailandepsins: Bacterial Products with Potent Histone Deacetylase Inhibitory Activities and Broad-Spectrum Antiproliferative Activities
- (2011) Cheng Wang et al. JOURNAL OF NATURAL PRODUCTS
- Epigenetic modifications as therapeutic targets
- (2010) Theresa K Kelly et al. NATURE BIOTECHNOLOGY
- Epigenetic modifications and human disease
- (2010) Anna Portela et al. NATURE BIOTECHNOLOGY
- Phase II Multi-Institutional Trial of the Histone Deacetylase Inhibitor Romidepsin As Monotherapy for Patients With Cutaneous T-Cell Lymphoma
- (2009) Richard L. Piekarz et al. JOURNAL OF CLINICAL ONCOLOGY
- Isoform-selective histone deacetylase inhibitors
- (2008) Anton V. Bieliauskas et al. CHEMICAL SOCIETY REVIEWS
- Epigenetic targets of HDAC inhibition in neurodegenerative and psychiatric disorders
- (2008) T ABEL et al. CURRENT OPINION IN PHARMACOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search